Skip to content

effect of Chandraprava Vati on prodromal symptoms of Madhumeha

Evaluating the efficacy of Chandraprava Vati on purvarupa of Madhumeha(Prediabetes): An open label randomized clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092507
Enrollment
176
Registered
2025-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Sanjib Kumar Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Fulfill prediabetes diagnostic criteria HbA1c = 5.7-6.4% Capable and willing of giving signed consent form BMI (25-30) kg/m2

Exclusion criteria

Exclusion criteria: Patients with H/o prior use of medication to treat diabetes or diagnosed with diabetes Newly diagnosed patients Currently using oral hypoglycemic agents Decompensated cardiac, kidney, hepatic failure, endocrine disorder. Patients having used any medication for DM or pre diabetes in last 1 month. Pregnant and lactating females. Who have participated in any other study within 1 month before this study conditions where there is an altered relationship between A1C and glycemia, such as; some hemoglobin variants, pregnancy (second and third trimesters and the postpartum period), glucose-6-phosphate dehydrogenase deficiency, HIV, hemodialysis, recent blood loss or transfusion, or erythropoietin therapy.

Design outcomes

Primary

MeasureTime frame
HbA1c should be less than 5.7%Timepoint: 6 month of study

Secondary

MeasureTime frame
Assessment of improvement in LFT, KFT, Lipid profile, CBC, HOMA-IR, HOMA-Beta, Assessment of improvement in Pipasa, Karapada Daha/Suptata, Alasya),Timepoint: 12 month of study

Countries

India

Contacts

Public ContactDr Sanjib Kumar Das

Affiliated to NCISM, Govt of India

ayursanjib@gmail.com09437292457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026